A Guanidinobenzol-Rich Polymer Overcoming Cascade Delivery Barriers for CRISPR-Cas9 Genome Editing

被引:3
作者
Liang, Shuang [1 ,2 ]
Ma, Ning [3 ]
Li, Xingang [4 ]
Yun, Kaiqing [1 ,2 ]
Meng, Qian-Fang [5 ]
Ma, Kongshuo [1 ,2 ]
Yue, Ludan [5 ,6 ,7 ,8 ,9 ,10 ]
Rao, Lang [5 ]
Chen, Xiaoyuan [6 ,7 ,8 ,9 ,10 ,11 ,12 ,13 ,14 ]
Wang, Zhaohui [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing 100050, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel Form, Beijing 100050, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China
[4] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing 100050, Peoples R China
[5] Shenzhen Bay Lab, Inst Biomed Hlth Technol & Engn, Shenzhen 518132, Peoples R China
[6] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Diagnost Radiol, Singapore 119074, Singapore
[7] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 119074, Singapore
[8] Natl Univ Singapore, Dept Chem & Biomol Engn, Yong Loo Lin Sch Med, Singapore 119074, Singapore
[9] Natl Univ Singapore, Dept Biomed Engn, Yong Loo Lin Sch Med, Singapore 119074, Singapore
[10] Natl Univ Singapore, Coll Design & Engn, Singapore 119074, Singapore
[11] Natl Univ Singapore, NUS Ctr Nanomed, Yong Loo Lin Sch Med, Nanomed Translat Res Program, Singapore 117597, Singapore
[12] Natl Univ Singapore, Clin Imaging Res Ctr, Ctr Translat Med, Yong Loo Lin Sch Med, Singapore 117599, Singapore
[13] ASTAR, Inst Mol & Cell Biol, Singapore 138673, Singapore
[14] Natl Univ Singapore, Theranost Ctr Excellence TCE, Yong Loo Lin Sch Med, Singapore 138667, Singapore
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
gene editing; CRISPR-Cas9; cascade delivery; guanidinobenzol-rich polymer; nanoparticle; MULTIPLEX; CELLS; RNA;
D O I
10.1021/acs.nanolett.4c00533
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The efficient cytosolic delivery of the CRISPR-Cas9 machinery remains a challenge for genome editing. Herein, we performed ligand screening and identified a guanidinobenzol-rich polymer to overcome the cascade delivery barriers of CRISPR-Cas9 ribonucleoproteins (RNPs) for genome editing. RNPs were stably loaded into the polymeric nanoparticles (PGBA NPs) by their inherent affinity. The polymer facilitated rapid endosomal escape of RNPs via a dynamic multiple-step cascade process. Importantly, the incorporation of fluorescence in the polymer helps to identify the correlation between cellular uptake and editing efficiency, increasing the efficiency up to 70% from the initial 30% for the enrichment of edited cells. The PGBA NPs efficiently deliver RNPs for in vivo gene editing via both local and systemic injections and dramatically reduce PCSK9 level. These results indicate that PGBA NPs enable the cascade delivery of RNPs for genome editing, showing great promise in broadening the therapeutic potential of the CRISPR-Cas9 technique.
引用
收藏
页码:6872 / 6880
页数:9
相关论文
共 35 条
[1]   Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli-Responsive Vehicles [J].
Cai, Weiqi ;
Luo, Tianli ;
Mao, Lanqun ;
Wang, Ming .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2021, 60 (16) :8596-8606
[2]   High-Efficiency Multiplex Genome Editing of Streptomyces Species Using an Engineered CRISPR/Cas System [J].
Cobb, Ryan E. ;
Wang, Yajie ;
Zhao, Huimin .
ACS SYNTHETIC BIOLOGY, 2015, 4 (06) :723-728
[3]   Therapeutic genome editing: prospects and challenges [J].
Cox, David Benjamin Turitz ;
Platt, Randall Jeffrey ;
Zhang, Feng .
NATURE MEDICINE, 2015, 21 (02) :121-131
[4]   High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells [J].
Fu, Yanfang ;
Foden, Jennifer A. ;
Khayter, Cyd ;
Maeder, Morgan L. ;
Reyon, Deepak ;
Joung, J. Keith ;
Sander, Jeffry D. .
NATURE BIOTECHNOLOGY, 2013, 31 (09) :822-+
[5]   Nanoparticles for CRISPR-Cas9 delivery [J].
Glass, Zachary ;
Li, Yamin ;
Xu, Qiaobing .
NATURE BIOMEDICAL ENGINEERING, 2017, 1 (11) :854-855
[6]   Rational Design of Poly(disulfide)s as a Universal Platform for Delivery of CRISPR-Cas9 Machineries toward Therapeutic Genome Editing [J].
Guo, Jiajing ;
Wan, Tao ;
Li, Bowen ;
Pan, Qi ;
Xin, Huhu ;
Qiu, Yayu ;
Ping, Yuan .
ACS CENTRAL SCIENCE, 2021, 7 (06) :990-1000
[7]   A European position on genome editing [J].
Hirsch, Francois ;
Levy, Yves ;
Chneiweiss, Herve .
NATURE, 2017, 541 (7635) :30-30
[8]   INHIBITORS OF LYSOSOMAL-ENZYMES - ACCUMULATION OF LIPOFUSCIN-LIKE DENSE BODIES IN THE BRAIN [J].
IVY, GO ;
SCHOTTLER, F ;
WENZEL, J ;
BAUDRY, M ;
LYNCH, G .
SCIENCE, 1984, 226 (4677) :985-987
[9]   LYSOSOMAL COMPOSITION IN CULTURED VASCULAR SMOOTH-MUSCLE CELLS - ELECTRON-PROBE ANALYSIS [J].
JAMESKRACKE, MR ;
SLOANE, BF ;
SHUMAN, H ;
SOMLYO, AP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (12) :6461-6465
[10]   The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells [J].
Lee, Ciaran M. ;
Cradick, Thomas J. ;
Bao, Gang .
MOLECULAR THERAPY, 2016, 24 (03) :645-654